Paul: A Plaque Psoriasis Patient | See Bit.ly/SkyriziPI

Visit bit.ly/SkyriziPI to see Full Prescribing Info & Medication Guide. Watch to learn more about the Uses and Important Safety Information for SKYRIZI (risankizumab-rzaa).
For adults with moderate to severe plaque psoriasis, hear Paul's experience with switching to SKYRIZI from HUMIRA® (adalimumab).
See what happened when some patients in a clinical study switched from HUMIRA to SKYRIZI: www.skyrizi.co...
SKYRIZI USE
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).
SAFETY CONSIDERATIONS
SKYRIZI may cause serious side effects, including:
- Serious allergic reactions: Stop using SKYRIZI and get emergency medical help right away if you get any symptoms of a serious allergic reaction.
- Infections: SKYRIZI may increase your risk of infections. Before starting treatment, your doctor should check you for infections and tuberculosis. Tell your doctor right away if you have an infection or symptoms of one.
Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI.
Also, tell your doctor if you plan to or recently received a vaccine.
Please see additional Important Safety Information here: www.skyrizi.co...
Learn more at www.SKYRIZI.com
Click to see HUMIRA® (adalimumab) Indication and Important Safety Information, including BOXED WARNING for Serious Infections and Malignancy: www.humira.com...
Please see the Full Prescribing Information, including the Medication Guide, for HUMIRA: bit.ly/HumiraPI